Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Active, not recruiting · NCT05797246 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Tumor Virus Infections, Urogenital Diseases, epithelial neoplasm, human papilloma virus infection, infectious disease, neoplasm, papilloma, respiratory system disorder, respiratory tract infectious disorder, sexually transmitted disease, squamous cell neoplasm, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-09-16 | NCT05797246 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |